Moore MJ - Search Results

1

A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575).

Richter S, Bedard PL, Chen EX, Clarke BA, Tran B, Hotte SJ, Stathis A, Hirte HW, Razak AR, Reedijk M, Chen Z, Cohen B, Zhang WJ, Wang L, Ivy SP, Moore MJ, Oza AM, Siu LL, McWhirter E. Richter S, et al. Among authors: moore mj. Invest New Drugs. 2014 Apr;32(2):243-9. doi: 10.1007/s10637-013-9965-4. Epub 2013 May 5. Invest New Drugs. 2014. PMID: 23645447 Free PMC article. Clinical Trial.

2

Phase I and pharmacokinetic study of novel L-nucleoside analog troxacitabine given as a 30-minute infusion every 21 days.

Bélanger K, Moore M, Baker SD, Dionne J, Maclean M, Jolivet J, Siu L, Soulières D, Wainman N, Seymour L. Bélanger K, et al. J Clin Oncol. 2002 May 15;20(10):2567-74. doi: 10.1200/JCO.2002.12.047. J Clin Oncol. 2002. PMID: 12011137 Clinical Trial.

3

Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial.

Nottage M, McLachlan SA, Brittain MA, Oza A, Hedley D, Feld R, Siu LL, Pond G, Moore MJ. Nottage M, et al. Among authors: moore mj. Support Care Cancer. 2003 Jan;11(1):41-7. doi: 10.1007/s00520-002-0378-8. Epub 2002 Jul 23. Support Care Cancer. 2003. PMID: 12527953 Clinical Trial.

4

Phase I and pharmacologic study of the human DNA methyltransferase antisense oligodeoxynucleotide MG98 given as a 21-day continuous infusion every 4 weeks.

Davis AJ, Gelmon KA, Siu LL, Moore MJ, Britten CD, Mistry N, Klamut H, D'Aloisio S, MacLean M, Wainman N, Ayers D, Firby P, Besterman JM, Reid GK, Eisenhauer EA. Davis AJ, et al. Among authors: moore mj. Invest New Drugs. 2003 Feb;21(1):85-97. doi: 10.1023/a:1022976528441. Invest New Drugs. 2003. PMID: 12795533 Clinical Trial.

5

Phase I and pharmacokinetic study of fostriecin given as an intravenous bolus daily for five consecutive days.

Lê LH, Erlichman C, Pillon L, Thiessen JJ, Day A, Wainman N, Eisenhauer EA, Moore MJ. Lê LH, et al. Among authors: moore mj. Invest New Drugs. 2004 Apr;22(2):159-67. doi: 10.1023/B:DRUG.0000011792.13160.b0. Invest New Drugs. 2004. PMID: 14739664 Clinical Trial.

6

Phase II study of activated charcoal to prevent irinotecan-induced diarrhea.

Michael M, Brittain M, Nagai J, Feld R, Hedley D, Oza A, Siu L, Moore MJ. Michael M, et al. Among authors: moore mj. J Clin Oncol. 2004 Nov 1;22(21):4410-7. doi: 10.1200/JCO.2004.11.125. J Clin Oncol. 2004. PMID: 15514383 Clinical Trial.

7

Simultaneous determination of OSI-774 and its major metabolite OSI-420 in human plasma by using HPLC with UV detection.

Zhang W, Siu LL, Moore MJ, Chen EX. Zhang W, et al. Among authors: moore mj. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jan 5;814(1):143-7. doi: 10.1016/j.jchromb.2004.10.016. J Chromatogr B Analyt Technol Biomed Life Sci. 2005. PMID: 15607718

8

A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix.

Knox JJ, Siu LL, Chen E, Dimitroulakos J, Kamel-Reid S, Moore MJ, Chin S, Irish J, LaFramboise S, Oza AM. Knox JJ, et al. Among authors: moore mj. Eur J Cancer. 2005 Mar;41(4):523-30. doi: 10.1016/j.ejca.2004.12.013. Epub 2005 Jan 22. Eur J Cancer. 2005. PMID: 15737556 Clinical Trial.

9

Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial.

Knox JJ, Hedley D, Oza A, Feld R, Siu LL, Chen E, Nematollahi M, Pond GR, Zhang J, Moore MJ. Knox JJ, et al. Among authors: moore mj. J Clin Oncol. 2005 Apr 1;23(10):2332-8. doi: 10.1200/JCO.2005.51.008. J Clin Oncol. 2005. PMID: 15800324 Clinical Trial.

10

Phase I study of the multidrug resistance inhibitor zosuquidar administered in combination with vinorelbine in patients with advanced solid tumours.

Lê LH, Moore MJ, Siu LL, Oza AM, MacLean M, Fisher B, Chaudhary A, de Alwis DP, Slapak C, Seymour L. Lê LH, et al. Among authors: moore mj. Cancer Chemother Pharmacol. 2005 Aug;56(2):154-60. doi: 10.1007/s00280-004-0942-7. Epub 2005 Apr 5. Cancer Chemother Pharmacol. 2005. PMID: 15809877 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

805 results

Search Page

Filters